Cargando…

How to Define Prehypertension in Diabetes/Metabolic Syndrome

Detalles Bibliográficos
Autores principales:	Leibowitz, Avshalom, Grossman, Ehud
Formato:	Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2009
Materias:	Hypertension and Diabetes Debates
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2811438/ https://www.ncbi.nlm.nih.gov/pubmed/19875564 http://dx.doi.org/10.2337/dc09-S323

Ejemplares similares

Should We Treat Prehypertension in Diabetes?: What are the cons?
por: Grossman, Ehud
Publicado: (2009)

Treatment of Prehypertension in Diabetes and Metabolic Syndrome: What are the pros?
por: Segura, Julian, et al.
Publicado: (2009)

White-Coat Hypertension Should Not Be Treated in Subjects With Diabetes
por: Bursztyn, Michael, et al.
Publicado: (2009)

Hypertension and Diabetes: What are the pros to treating early surrogates?
por: Schmieder, Roland E.
Publicado: (2009)

Should White-Coat Hypertension in Diabetes Be Treated? Pro
por: Mancia, Giuseppe, et al.
Publicado: (2009)

Hypertension and Diabetes: Should We Treat Early Surrogates?: What are the cons?
por: Nilsson, Peter M.
Publicado: (2009)

Should 24-h Ambulatory Blood Pressure Monitoring Be Done in Every Patient With Diabetes?
por: Parati, Gianfranco, et al.
Publicado: (2009)

Blood Pressure: The Lower, the Better: The con side
por: Grossman, Ehud
Publicado: (2011)

Ambulatory Blood Pressure Monitoring in the Diagnosis and Management of Hypertension
por: Grossman, Ehud
Publicado: (2013)

Diuretic Treatment of Hypertension
por: Grossman, Ehud, et al.
Publicado: (2011)

Endothelial Factors and Diabetic Nephropathy
por: Karalliedde, Janaka, et al.
Publicado: (2011)

Endothelial Dysfunction in Diabetes: The role of reparatory mechanisms
por: Avogaro, Angelo, et al.
Publicado: (2011)

Monitoring Kidney Function and Albuminuria in Patients With Diabetes
por: Lambers Heerspink, Hiddo J., et al.
Publicado: (2011)

RAS Blockade for Every Diabetic Patient: Pro and Con
por: Ruilope, Luis M., et al.
Publicado: (2011)

Antihypertensive Treatment and Blood Pressure in Diabetic and Nondiabetic Patients: The lower, the better?
por: Mancia, Giuseppe, et al.
Publicado: (2011)

Limitations and Future Treatment Options in Type 2 Diabetes With Renal Impairment
por: Ritz, Eberhard
Publicado: (2011)

Prognostic Value of Blood Pressure Variability and Average Blood Pressure Levels in Patients With Hypertension and Diabetes
por: Parati, Gianfranco, et al.
Publicado: (2013)

Benefits of Tight Blood Pressure Control in Diabetic Patients With Hypertension: Importance of early and sustained implementation of effective treatment strategies
por: Parati, Gianfranco, et al.
Publicado: (2011)

The combination of amlodipine/valsartan 5/160 mg produces less peripheral oedema than amlodipine 10 mg in hypertensive patients not adequately controlled with amlodipine 5 mg
por: Schrader, J, et al.
Publicado: (2009)

Individualization of Antihypertensive Drug Treatment
por: Mancia, Giuseppe, et al.
Publicado: (2013)

Intolerance to Statins: Mechanisms and Management
por: Bitzur, Rafael, et al.
Publicado: (2013)

Familial history of hypertension as a predictor of increased arterial stiffness in normotensive offspring
por: Youssef, Ghada, et al.
Publicado: (2017)

Use of machine-learning algorithms to determine features of systolic blood pressure variability that predict poor outcomes in hypertensive patients
por: Lacson, Ronilda C, et al.
Publicado: (2018)

The Role of Nocturnal Blood Pressure and Sleep Quality in Hypertension Management
por: Cappuccio, Francesco P
Publicado: (2020)

The chaos of hypertension guidelines for chronic kidney disease patients
por: Castillo-Rodriguez, Esmeralda, et al.
Publicado: (2019)

(Pro)renin Receptor and Blood Pressure Regulation: A Focus on the Central Nervous System
por: Souza, Lucas A.C., et al.
Publicado: (2022)

Most Recent Trials and Advances in Hypertension
por: Rey-Rañal, Elías Martínez, et al.
Publicado: (2022)

Childhood Metabolic Syndrome: Must we define it to deal with it?
por: Weiss, Ram
Publicado: (2011)

Hypertension : physiopathology and treatment /
Publicado: (1977)

High-Fructose Diet Increases Renal ChREBPβ Expression, Leading to Intrarenal Fat Accumulation in a Rat Model with Metabolic Syndrome
por: Bier, Ariel, et al.
Publicado: (2022)

Lower is better in hypertension, but how low should blood pressure be targeted?
por: Touyz, Rhian M.
Publicado: (2016)

Defining re-implementation
por: Moyal-Smith, Rachel, et al.
Publicado: (2023)

Uncontrolled hypertension in patients with type 2 diabetes: What are the correlates?
por: Rabizadeh, Soghra, et al.
Publicado: (2021)

Impact of sustained hypertension on new cardiovascular events in patients with type 2 diabetes: KAMOGAWA‐HBP study
por: Yoshimura, Takashi, et al.
Publicado: (2022)

Defining “mutation” and “polymorphism” in the era of personal genomics
por: Karki, Roshan, et al.
Publicado: (2015)

A stimulus to define informatics and health information technology
por: Hersh, William
Publicado: (2009)

Defining & assessing the quality, usability, and utilization of immunization data
por: Bloland, Peter, et al.
Publicado: (2019)

Defining mental illnesses: can values and objectivity get along?
por: Sisti, Dominic, et al.
Publicado: (2013)

Architectural frameworks: defining the structures for implementing learning health systems
por: Lessard, Lysanne, et al.
Publicado: (2017)

Why Australia needs to define obesity as a chronic condition
por: Opie, C. A., et al.
Publicado: (2017)

Cannot write session to /tmp/vufind_sessions/sess_q8ib3b43ishbh4kp30s8dmu3rv